Assembly Biosciences (ASMB) Enterprise Value: 2015-2025
Historic Enterprise Value for Assembly Biosciences (ASMB) over the last 11 years, with Sep 2025 value amounting to -$36.1 million.
- Assembly Biosciences' Enterprise Value fell 3333.79% to -$36.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$314.2 million, marking a year-over-year increase of 10.56%. This contributed to the annual value of -$11.8 million for FY2024, which is 84.58% up from last year.
- As of Q3 2025, Assembly Biosciences' Enterprise Value stood at -$36.1 million, which was down 157.00% from $63.4 million recorded in Q2 2025.
- Over the past 5 years, Assembly Biosciences' Enterprise Value peaked at $63.4 million during Q2 2025, and registered a low of -$76.4 million during Q4 2023.
- Moreover, its 3-year median value for Enterprise Value was -$19.3 million (2025), whereas its average is -$15.7 million.
- As far as peak fluctuations go, Assembly Biosciences' Enterprise Value tumbled by 22,510.50% in 2024, and later soared by 360.79% in 2025.
- Quarterly analysis of 5 years shows Assembly Biosciences' Enterprise Value stood at -$35.1 million in 2021, then climbed by 19.69% to -$28.2 million in 2022, then tumbled by 170.81% to -$76.4 million in 2023, then surged by 84.58% to -$11.8 million in 2024, then tumbled by 3,333.79% to -$36.1 million in 2025.
- Its Enterprise Value stands at -$36.1 million for Q3 2025, versus $63.4 million for Q2 2025 and -$19.3 million for Q1 2025.